Explore Strategic Business Insight Track – CONVERGE 2021

Gain deeper understanding of key business trends affecting the dental benefits industry with the following sessions in this track: Dental plan strategies for small group growth or retention Understanding health…

Massachusetts Legislation Update

On July 27, the Massachusetts Joint Committee on Financial Services considered a number of bills around dental insurance, including bills on assignment of benefits, medical loss ratio, so-called “dental patient…

Andrews

…Reform for the Specialty Benefits Products of UnitedHealthcare, President of Dental Benefit Providers of California, Vice President and Chief Financial Officer of PacifiCare Dental & Vision and Executive Vice President,…

CMS Extends Transparency Rule Compliance Deadline

…billed charges as well as its enforcement of the requirement that plans and issuers must provide an Advanced Explanation of Benefits. Please contact Sr. Government Affairs Analyst Owen Urech for

2025 Longevity Recognition

…YEARS Blue Cross Blue Shield of NC Fluent SKYGEN 15 YEARS Companion Life Healthscape Advisors Primecare Benefits 10 YEARS Delta Dental of Wisconsin 5 YEARS Cotiviti Amy Marko & Associates…

Strategic Planning Update

This content is an exclusive benefit for NADP members. If you’re a member of NADP, login, and you’ll get immediate access. If you are not yet a member of NADP,…

Dental Premiums Maintain Affordability According to NADP

Dental Premiums Maintain Affordability According to NADP The NADP Dental Benefits Report: 2023 Premium reveals premiums continue a trend of increases well below the inflation rate, with the average premium…

Advocacy in Action

Advocacy in Action (AIA) is the dental benefits industry’s inaugural advocacy fly-in located in Washington, D.C. This is a very exciting opportunity for the industry to deliver its message and…

2021 Dental Benefits Reports to be Published Soon

…Benefit Utilization Report includes data on non-DHMO dental insurance paid dental procedures per 1,000 enrollees by month, by state and by benefit sponsor (group, individual, and Medicare Advantage). The report…

Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients

…opportunities, and the timing and success of any related clinical trials; the ability to realize anticipated benefits and synergies from the acquisition of MyoScience; the ability to successfully integrate iovera°…